OncoTracker Inc.

Deals In March MyungMoon Bio To Sell ACell's Wound Matrix Products In South Korea ACell Inc. granted MyungMoon Bio Co. Ltd. exclusive rights to market and distribute its wound management matrix pr

T-cell immunotherapy specialist Tmunity Therapeutics Inc. hopes to develop the first drug for a rare pediatric cancer called diffuse intrinsic pontine glioma (DIPG) after licensing global rights to

Financings Total biopharma financing during the fourth quarter of 2017 amounted to $14.5 billion, a strong finish to a year that benefitted from renewed investor confidence in the industry and an open

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustan